Trials / Completed
CompletedNCT05337228
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301
A Randomized, Open-label, Multi-center Phase III Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301 in Postoperative Patients Requiring Peripheral Parenteral Nutrition
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the safety and efficacy of IN-C006 Peri inj. and RPN301 in postoperative patients requiring central parenteral nutrition.
Detailed description
This study is a randomized, open-label, phase 3 design. The subject will be assigned to one of the two treatment groups (IN-C006 Peri inj. or RPN301)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IN-C006 Peri inj. | IN-C006 peri inj. will be injected continuously for 3 days. |
| DRUG | RPN301 | RPN301 will be injected continuously for 3 days. |
Timeline
- Start date
- 2022-08-09
- Primary completion
- 2023-02-10
- Completion
- 2023-02-24
- First posted
- 2022-04-20
- Last updated
- 2023-09-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05337228. Inclusion in this directory is not an endorsement.